BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2273597)

  • 21. [Acetate-free on-line PHF: how to improve hyperacetatemia and haemodynamic tolerance].
    Coll E; Pérez-García R; Martín de Francisco AL; Galcerán J; García-Osuna R; Martín-Malo A; Martínez-Castelao A; Sánchez B; Llopis R; Alvarez de Lara MA
    Nefrologia; 2009; 29(2):156-62. PubMed ID: 19396322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acetate free biofiltration. Effects on peripheral blood monocyte activation and cytokine release.
    Carozzi S; Nasini MG; Caviglia PM; Schelotto C; Santoni O; Atti M
    ASAIO J; 1992; 38(1):52-4. PubMed ID: 1313318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Will there be acetate in dialysis solutions for the foreseeable future?].
    Bolasco P; Panichi V; Paletti S; Mancini E
    G Ital Nefrol; 2011; 28(4):359-68. PubMed ID: 21809305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerance of acetate free biofiltration: a central Italian multicenter trial.
    Albertazzi A; Palmieri PF; Mastrangelo E
    Kidney Int Suppl; 1993 Jun; 41():S188-94. PubMed ID: 8320918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The faster potassium-lowering effect of high dialysate bicarbonate concentrations in chronic haemodialysis patients.
    Heguilén RM; Sciurano C; Bellusci AD; Fried P; Mittelman G; Rosa Diez G; Bernasconi AR
    Nephrol Dial Transplant; 2005 Mar; 20(3):591-7. PubMed ID: 15687112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved cardiovascular variables during acetate free biofiltration.
    Schrander-vd Meer AM; ter Wee PM; Kan G; Donker AJ; van Dorp WT
    Clin Nephrol; 1999 May; 51(5):304-9. PubMed ID: 10363631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium exposure and removal in chronic hemodialysis patients.
    Sigrist M; McIntyre CW
    J Ren Nutr; 2006 Jan; 16(1):41-6. PubMed ID: 16414440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between intradialytic hypotension in patients undergoing routine hemodialysis and use of acetate compared in bicarbonate dialysate.
    Thaha M; Yogiantoro M; Soewanto ; Pranawa
    Acta Med Indones; 2005; 37(3):145-8. PubMed ID: 16138418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correction of metabolic acidosis on serum albumin and protein catabolism in hemodialysis patients.
    Movilli E; Viola BF; Camerini C; Mazzola G; Cancarini GC
    J Ren Nutr; 2009 Mar; 19(2):172-7. PubMed ID: 19218045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lipid peroxidation and the antioxidant system in bicarbonate hemodialysis and acetate-free biofiltration].
    Eiselt J; Racek J; Holecek V; Jerábek Z; Opatrný K
    Vnitr Lek; 1995 Apr; 41(4):235-9. PubMed ID: 7762187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short term study on relative merits of acetate and bicarbonate dialysis.
    Gurudev KC; Pathak V; Prabhakar KS; Bhaskar S; Prakash KC; Prabhakaran ; Mani MK
    J Assoc Physicians India; 1991 Dec; 39(12):921-4. PubMed ID: 1816218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective randomised European multicentre study of medium-long run mortality and morbidity comparing acetate-free biofiltration and bicarbonate dialysis.
    Santoro A; Panzetta G; Tessitore N; Atti M; Mancini E; Esteban J; London G; Ara JM; Miguel JL; Neumann KH; Opatrny K; Perez R; Perrone B; Wizemann V; Zucchelli P
    J Nephrol; 1999; 12(6):375-82. PubMed ID: 10626827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucose-added dialysis fluid prevents asymptomatic hypoglycaemia in regular haemodialysis.
    Burmeister JE; Scapini A; da Rosa Miltersteiner D; da Costa MG; Campos BM
    Nephrol Dial Transplant; 2007 Apr; 22(4):1184-9. PubMed ID: 17272314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acetate-free hemodialysis: what does it mean?].
    Petitclerc T; Diab R; Le Roy F; Mercadal L; Hmida J
    Nephrol Ther; 2011 Apr; 7(2):92-8. PubMed ID: 21130720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patients with complex arrhythmias during and after haemodialysis suffer from different regimens of potassium removal.
    Santoro A; Mancini E; London G; Mercadal L; Fessy H; Perrone B; Cagnoli L; Grandi E; Severi S; Cavalcanti S
    Nephrol Dial Transplant; 2008 Apr; 23(4):1415-21. PubMed ID: 18065796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the factors influencing bicarbonate balance during acetate-free biofiltration.
    Santoro A; Spongano M; Ferrari G; Bolzani R; Augella F; Borghi M; Briganti M; Cagnoli L; Docci D; Feletti C
    Kidney Int Suppl; 1993 Jun; 41():S184-7. PubMed ID: 8320917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of metabolic acidosis on serum albumin and other nutritional parameters in long-term CAPD patients.
    Kang SW; Lee SW; Lee IH; Kim BS; Choi KH; Lee HY; Han DS
    Adv Perit Dial; 1997; 13():249-52. PubMed ID: 9360692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biofiltration without buffering substances in the dialysate].
    Quarello F; Boero R; Martina G; Formica M; Guarena C; Beltrame G; Scalzo B; Forneris G; Piccoli G
    Minerva Urol Nefrol; 1990; 42(1):43-6. PubMed ID: 2167517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interrelationship between plasma leptin concentration and severity of metabolic acidosis in haemodialysed patients with chronical renal failure.
    Kokot F; Chudek J; Adamczak M; Wieçek A
    Exp Clin Endocrinol Diabetes; 2001; 109(7):370-3. PubMed ID: 11573148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.